AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF
Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.
Gespeichert in:
| Hauptverfasser: | , , , , |
|---|---|
| Format: | Patent |
| Sprache: | eng |
| Schlagworte: | |
| Online-Zugang: | Volltext bestellen |
| Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
| container_end_page | |
|---|---|
| container_issue | |
| container_start_page | |
| container_title | |
| container_volume | |
| creator | GUZZO PETER R SURMAN MATTHEW DAVID HENDERSON ALAN JOHN HADDEN MARK FREEMAN EMILY ELIZABETH |
| description | Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention. |
| format | Patent |
| fullrecord | <record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_US2012058939A9</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>US2012058939A9</sourcerecordid><originalsourceid>FETCH-epo_espacenet_US2012058939A93</originalsourceid><addsrcrecordid>eNqNjE0LgkAUAL10iOo_POiq4AdBHl_uUxfXfeKuB7uIxHaKEuz_k0W3Lp3mMMOsvRnPeJJZnylGVaGmQGrBigC1gB_X9G3Lit-UQmqCOiuDaGktFqylscaHmmzJwgDnUGMldeF_Xp0hsCW1xPnWW13H2-x2X268fU52ObnpMbh5Gi_u7p5DZ-IwisPDMU1STJP_qhdaHDl8</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF</title><source>esp@cenet</source><creator>GUZZO PETER R ; SURMAN MATTHEW DAVID ; HENDERSON ALAN JOHN ; HADDEN MARK ; FREEMAN EMILY ELIZABETH</creator><creatorcontrib>GUZZO PETER R ; SURMAN MATTHEW DAVID ; HENDERSON ALAN JOHN ; HADDEN MARK ; FREEMAN EMILY ELIZABETH</creatorcontrib><description>Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.</description><language>eng</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2012</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120308&DB=EPODOC&CC=US&NR=2012058939A9$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,780,885,25564,76547</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20120308&DB=EPODOC&CC=US&NR=2012058939A9$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>GUZZO PETER R</creatorcontrib><creatorcontrib>SURMAN MATTHEW DAVID</creatorcontrib><creatorcontrib>HENDERSON ALAN JOHN</creatorcontrib><creatorcontrib>HADDEN MARK</creatorcontrib><creatorcontrib>FREEMAN EMILY ELIZABETH</creatorcontrib><title>AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF</title><description>Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2012</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNqNjE0LgkAUAL10iOo_POiq4AdBHl_uUxfXfeKuB7uIxHaKEuz_k0W3Lp3mMMOsvRnPeJJZnylGVaGmQGrBigC1gB_X9G3Lit-UQmqCOiuDaGktFqylscaHmmzJwgDnUGMldeF_Xp0hsCW1xPnWW13H2-x2X268fU52ObnpMbh5Gi_u7p5DZ-IwisPDMU1STJP_qhdaHDl8</recordid><startdate>20120308</startdate><enddate>20120308</enddate><creator>GUZZO PETER R</creator><creator>SURMAN MATTHEW DAVID</creator><creator>HENDERSON ALAN JOHN</creator><creator>HADDEN MARK</creator><creator>FREEMAN EMILY ELIZABETH</creator><scope>EVB</scope></search><sort><creationdate>20120308</creationdate><title>AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF</title><author>GUZZO PETER R ; SURMAN MATTHEW DAVID ; HENDERSON ALAN JOHN ; HADDEN MARK ; FREEMAN EMILY ELIZABETH</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_US2012058939A93</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>eng</language><creationdate>2012</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>GUZZO PETER R</creatorcontrib><creatorcontrib>SURMAN MATTHEW DAVID</creatorcontrib><creatorcontrib>HENDERSON ALAN JOHN</creatorcontrib><creatorcontrib>HADDEN MARK</creatorcontrib><creatorcontrib>FREEMAN EMILY ELIZABETH</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>GUZZO PETER R</au><au>SURMAN MATTHEW DAVID</au><au>HENDERSON ALAN JOHN</au><au>HADDEN MARK</au><au>FREEMAN EMILY ELIZABETH</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF</title><date>2012-03-08</date><risdate>2012</risdate><abstract>Novel MCH-1 receptor antagonists are disclosed. These compounds are used in the treatment of various disorders, including obesity, anxiety, depression, non-alcoholic fatty liver disease, and psychiatric disorders. Methods of making these compounds are also described in the present invention.</abstract><oa>free_for_read</oa></addata></record> |
| fulltext | fulltext_linktorsrc |
| identifier | |
| ispartof | |
| issn | |
| language | eng |
| recordid | cdi_epo_espacenet_US2012058939A9 |
| source | esp@cenet |
| subjects | CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS |
| title | AZABICYCLOALKANE-INDOLE AND AZABICYCLOALKANE-PYRROLO-PYRIDINE MCH-1 ANTAGONISTS, METHODS OF MAKING, AND USE THEREOF |
| url | https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-29T08%3A02%3A14IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=GUZZO%20PETER%20R&rft.date=2012-03-08&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EUS2012058939A9%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true |